“Gallic Acid: A Potential Therapeutic Agent for Managing Diabetes-Associated Neuroinflammation and Cognitive Decline” (2025) Nigerian Journal of Neuroscience, 16(1), pp. 1–8. doi:10.47081/njn2025.16.1/001.